GLAUKOS Corp·4

Mar 27, 8:31 PM ET

Gilliam Joseph E 4

4 · GLAUKOS Corp · Filed Mar 27, 2026

Research Summary

AI-generated summary of this filing

Updated

GLAUKOS (GKOS) President Joseph Gilliam Receives Stock Awards

What Happened Joseph E. Gilliam, President and Chief Operating Officer of GLAUKOS Corp (GKOS), was reported to have acquired a total of 98,789 shares on March 25, 2026. The filing shows five award-type acquisitions (RSUs and derivative-based awards/options portions) totaling 98,789 shares, each recorded at $0 per share — i.e., these were vested/awarded shares or portions of previously granted equity, not open-market purchases.

Key Details

  • Transaction date: March 25, 2026; Form 4 filed March 27, 2026 (appears timely).
  • Reported entries: 5,829; 17,792; 16,462 (derivative); 21,955 (derivative); 36,751 (derivative) — total 98,789 shares — all recorded at $0.00 per share.
  • Shares owned after transaction: not specified in the supplied excerpt of the filing.
  • Nature of awards: Includes restricted stock units (RSUs) and derivative awards/options portions tied to multi-year performance goals and/or time-based vesting; some portions remain unvested per the footnotes.
  • Notable footnote points (from filing):
    • Portions of awards come from prior grants (e.g., March 14, 2024 and March 22, 2023) whose vesting was contingent on multi-year operational targets; the Compensation/Nominating & Governance Committee determined certain targets were achieved as of March 25, 2026, triggering earned portions that will vest/deliver in March 2026.
    • Some RSU grants vest pro rata over four years (25% each year); other awards are performance-vesting portions of stock options granted March 24, 2022, with staggered vesting (part in March 2026, part in December 2026).
    • Footnotes indicate specific counts of RSUs that remain unvested (e.g., 31,962 and 49,754 in two noted footnotes).

Context

  • These transactions are awards/vesting events (transaction code A) rather than cash purchases or open-market sales. Acquisitions at $0 typically reflect issuance upon vesting of RSUs or conversion of earned option portions, not an outlay by the insider.
  • For retail investors, award/vesting filings signal that performance or timing conditions were met per company committees; they are informative about compensation realization but do not necessarily indicate the insider’s view on near-term stock direction.

Insider Transaction Report

Form 4
Period: 2026-03-25
Gilliam Joseph E
PRESIDENT & COO
Transactions
  • Award

    Common Stock

    [F1][F2]
    2026-03-25+5,82978,369 total
  • Award

    Common Stock

    [F3][F4]
    2026-03-25+17,79296,161 total
  • Award

    Stock Option (Right to Buy)

    [F5][F6]
    2026-03-25+16,46271,475 total
    Exercise: $55.18Exp: 2032-03-24Common Stock (16,462 underlying)
  • Award

    Stock Option (Right to Buy)

    [F7]
    2026-03-25+21,95552,668 total
    Exercise: $55.18From: 2026-03-25Exp: 2032-03-24Common Stock (21,955 underlying)
  • Award

    Stock Option (Right to Buy)

    [F8]
    2026-03-25+36,75136,751 total
    Exercise: $48.46From: 2026-03-25Exp: 2033-03-14Common Stock (36,751 underlying)
Footnotes (8)
  • [F1]Represents shares of common stock underlying a portion of an award of restricted stock units previously granted by the Issuer on March 14, 2024, the vesting of which was subject to the Issuer's achievement of certain pre-determined operational targets over a multi-year performance period. The Compensation, Nominating and Governance Committee of the Issuer's Board of Directors determined on March 25, 2026 that certain of the operational targets had been achieved. The number of shares reported herein consists of the portion of the award that was deemed earned based upon the achievement of the operational target. 100% of the number of shares of common stock reported herein will vest and be delivered in March 2026.
  • [F2]Includes 31,962 restricted stock units that have not yet vested or been delivered to the Reporting Person.
  • [F3]Granted by the Issuer in the form of restricted stock units which vest over a four-year period, with 25% to vest on each anniversary of the grant date
  • [F4]Includes 49,754 restricted stock units that have not yet vested or been delivered to the Reporting Person.
  • [F5]Represents a portion of an option to purchase shares of common stock previously granted by the Issuer on March 24, 2022, the vesting of which was subject to the Issuer's achievement of certain pre-determined operational targets over a multi-year performance period. The Compensation Committee determined on December 15, 2022 that certain of the operational targets had been achieved. The number of shares of common stock subject to the stock option as reported herein consists of the portion of the award that was earned based upon the achievement of the operational targets.
  • [F6]50% of the portion of the option reported herein will vest and become exercisable in March 2026. 50% of the portion of the option reported herein will vest and become exercisable in December 2026.
  • [F7]Represents a portion of an option to purchase shares of common stock previously granted by the Issuer to the Reporting Person on March 24, 2022 in connection with his promotion to President and Chief Operating Officer, the vesting of which was subject to the Issuer's achievement of certain multi-year performance goals. The Compensation, Nominating & Governance Committee determined on March 25, 2026 the level of achievement for the fourth year of the multi-year performance period. The number of shares of common stock subject to the stock option reported herein consists of the portion of the shares subject to the stock option that vested with respect to 100% of the fourth-year performance goal.
  • [F8]Represents shares of common stock underlying a portion of an award of restricted stock units previously granted by the Issuer on March 22, 2023, the vesting of which was subject to the Issuer's achievement of certain pre-determined operational targets over a multi-year performance period. The Compensation, Nominating and Governance Committee of the Issuer's Board of Directors determined on March 25, 2026 that certain of the operational targets had been achieved. The number of shares of common stock subject to the stock option as reported herein consists of the portion of the award that was earned based upon the achievement of the operational targets.
Signature
Diana Scherer, Attorney-in-Fact|2026-03-27

Documents

1 file
  • 4
    form4-03282026_120304.xmlPrimary